LAG3 and ovarian carcinoma: In ovarian cancer, compared to PD1+LAG3– or LAG3–PD1– tumor-infiltrating lymphocytes, the triple positive expression of CD8, LAG3, and PD1 in lymphocytes can potently inhibit the production of TNF-α, IFN-γ, and IL-2 (32).